Viewing Study NCT02549651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-02-13 @ 6:48 AM
Study NCT ID: NCT02549651
Status: COMPLETED
Last Update Posted: 2019-02-27
First Post: 2015-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)
Sponsor: MedImmune LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DLBCL View
None MEDI4736 View
None durvalumab View
None tremelimumab View
None AZD9150 View
None anti-PD-L1 View
None anti-CTLA-4 View
None immunotherapy View
None IMTC View
None STAT3 View